Search

Introduction: In our research, the data of lung cancer patients operated via VATS and thoracotomy methods were investigated. In the evaluation performed by using versatile parameters, both methods were compared on the basis of objective criteria. Our study was carried out in order to assess the outcomes of both methods. Materials and Methods: 232 patients who underwent surgery with a diagnosis of lung cancer of various stages between the dates of January 2016 and June 2021 were involved in the research, and the patients' data were retrospectively scanned. To ensure balance between both groups, cases that were operated on for benign causes, performed pneumonectomy, received neoadjuvant, underwent chest wall resection, and cases converted to open from VATS were excluded from the research. The patients' hospitalization, amount of drainage, count of dissected lymph nodes, stages, complications and early mortality were reviewed. Results: There were 81 patients underwent VATS lobectomy and 151 patients underwent thoracotomy, in our study. The mean age was 63.5 in the thoracotomy group, and, 61.8 in VATS group. In the thoracotomy group, there were 31 female and 120 male patients; and in VATS group, 28 female and 53 male patients. The hospitalization times were shorter in VATS group; however, it was not statistically significant. In thoracotomy group, drainage amount and the count of lymph node dissections were significantly higher. The stage was determined significantly earlier in VATS group. Despite the rate of complication was lower in VATS group, there was no statistical difference between the both groups. Early mortality rates were comparable. Conclusion: Even though our research has limitations, we believe that we will gain better outcomes as our learning curve enhances in VATS. [ABSTRACT FROM AUTHOR]

Copyright of Southern Clinics of Istanbul Eurasia is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Southern Clinics of Istanbul Eurasia is the property of KARE Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Background: Pulmonary sarcomatoid carcinomas are very rare lung neoplasms, and no consensus exists regarding their optimal treatment. The prognosis of sarcomatoid carcinomas has been reported to be unfavorable compared with non-small-cell lung cancers; however, prognostic factors in patients undergoing surgery for sarcomatoid carcinomas remain unclear. Aims: To analyze clinicopathologic prognostic factors and survival outcomes in patients who underwent surgery for pulmonary sarcomatoid carcinoma. Study Design: Retrospective cross-sectional study. Methods: We designed a retrospective cross-sectional study in patients who underwent surgery for pulmonary sarcomatoid carcinomas and statistically analyzed the prognostic factors regarding clinicopathologic features with respect to survival outcomes. Results: We had a total of 44 patients with sarcomatoid carcinoma who had pulmonary resection. Sex distribution was 34 (77%) males and 10 (22.7%) females, which was determined by declaration. The mean age of patients was 57.3 ± 16 years with a median of 60 years. The 5-year progression-free survival and overall survival rates were 59% and 58%, respectively. The 5-year survival rates were significantly different for tumors > 5 cm (P = 0.044), tumorstatus (T) (P=0.016), lymph node status (N) (P=0.005), and pathologic tumor-node-metastasis (TNM) stage (P = 0.0001 ). However, histologic subtype (P = 0.628) and adjuvant treatment (P = 0.804) did not have any significant effect on survival. Similarly, the significant prognostic factors in univariate analysis were tumor size (P = 0.085), T status (P = 0.005), N status (P = 0.028), and pathologic TNM stage (P = 0.0001). Multivariate analysis showed only T status (P = 0.058), N status (P = 0.018), and pathologic TNM stage (P = 0.019) as independent prognostic factors, with statistical power of 87%, 43.1% and 21.2%. Conclusion: Surgery appears to be an optimal treatment with favorable outcomes for patients with pulmonary sarcomatoid carcinoma. Patients with small tumors at earlier stages are very likely to benefit from surgery, regardless of histologic subtype. [ABSTRACT FROM AUTHOR]

Objective: A previously unknown contagious disease, which later turned out to be a worldwide pandemic originated from Wuhan, capital of Hubei province in China by the end of 2019. While this upheaval affected numerous countries tragically, mortality rate and necessity for ICU were relatively low in Turkey. Methods: A total of 166 patients (65 at ICU, 101 at pandemic service) were analyzed to uncover effect of radiological and laboratory parameters on prognosis in COVID-19. One hundred and one patients (60.8%) were treated in pandemic service and 65 (39.15%) were treated in ICU. Results: Mean age of the patients in pandemic service was 61.1±16.2 (23-93) and of patients in ICU was 64.6±15.7 (15-90) (p>0.05). Initial mean CRP value for pandemic service group was 68.14±6.5 mg/dL (3.11-271), whereas it was 117.07±11.5 mg/dL (0-360) for ICU (p<0.05). Mean D-dimer value for the patients in ICU was 5572.2±1075.6 ng/mL and for the patients in pandemic service it was 1904.9±290.7 ng/mL (p<0.05). There was a correlation between CRP and D-dimer values (p<0.05). Of 66 patients in ICU group, 30(49.2%) had early stage CT findings, 22 (36.1%) had progressing stage CT findings and 9 (14.8%) had severe stage CT findings. However, of 101 patients in pandemic service group, 67 (66.9%) had early stage CT findings, 32 (31.7%) had progressing stage CT findings and 2 (2%) had severe stage CT findings. Conclusion: CT staging is a substantial prognostic factor and may help clinicians decide treatment modality. Furthermore, CRP and D-dimer values are also prognostic during follow- up. Thus, the necessity of taking these parameters into consideration while implementing treatment algorithms has emerged. As a conclusion, CT stage, CRP and D-Dimer values should be adopted as crucial prognostic factors in order to provide efficient healthcare. [ABSTRACT FROM AUTHOR]

Objective: During the pandemic, various measures have been taken from the Ministry of Health to family health centers to minimize the effects of COVID-19 on both society and the healthcare system. It is crucial to quickly revise the hospital for such a large pandemic crisis to effectively treat patients that require hospitalization or intensive care. It is vital to act quickly, postpone the treatment of elective patients, and make room for patients affected by the pandemic. It is also important that the same diagnostic and treatment algorithms are followed all over the country to get reliable feedback. In this study, we share our experience in the successful management of the COVID-19 outbreak between March 11 and May 7, 2020, and investigate the role of the hospital organization in the success of the treatment. Methods: Kartal Dr. Lütfi Kırdar Training and Research Hospital has been declared as a pandemic hospital by the Ministry of Health on March 11, 2020. To hospitalize patients diagnosed with COVID-19, 500 pandemic patient beds were arranged in 31 clinics. Results: Until this date, 37350 polyclinic examinations have been performed for COVID-19. The highest number of outpatient examinations was reached by 1656 on April 20, 2020. By the end of March, there was a noticeable increase in both the number of inpatient and outpatient clinics. Through pandemics, a total of 2536 patients was hospitalized, 163 of them were children. While 2087 (82%) of our inpatients were discharged, 255 (10%) of the patients are still being treated in our institution. Conclusion: In conclusion, we think that in the diagnosis and treatment of COVID-19, having adequate physical space and sufficient workforce, and carrying out the treatment process with a good organizational chart will help us treat patients in a shorter time and will contribute to the reduction of morbidity and mortality. [ABSTRACT FROM AUTHOR]

Background: In this study, we aimed to investigate the prognostic effect of lymph node dissection in secondary lung tumor metastasectomies., Methods: Between January 2001 and December 2015, a total of 201 patients (122 males, 79 females; mean age: of 41.4±19.2 years; range, 3 to 79 years) who had pulmonary metastasectomy due to colorectal carcinoma, renal cell carcinoma, and soft tissue - skeletal sarcomas were retrospectively analyzed. The clinicopathological features of the patients, overall survival, and complication rates according to the presence of lymph node dissection were evaluated., Results: The most common histopathological subtype was a sarcoma in 118 (58.7%) patients, followed by colorectal carcinoma in 63 (31.3%) patients, and renal cell carcinoma in 20 (10%) patients. A total of 88 (43.7%) patients underwent systematic lymph node dissection with pulmonary metastasectomy. The mean overall survival of patients with and without lymph node dissection were 49±5.9 (95% confidence interval 37.3-60.6) and 26±4.4 (95% confidence interval 17.2-34.7) months, respectively (p=0.003). The five-year survival rates in colorectal carcinoma, renal cell carcinoma, and sarcoma were 52%, 30%, and 23%, respectively (p=0.002). Locoregional recurrences occurred in 15 (35.7%) patients in the lymph node dissection group and in 23 (60.5%) patients in the non-lymph node dissection group (p=0.026). Lymph node dissection did not show a significant relationship regarding to postoperative complications (p=0.09)., Conclusion: Lymph node dissection following pulmonary metastasectomy may improve the overall survival and reduce locoregional recurrence, without any increase in morbidity and mortality., Competing Interests: Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article., (Copyright © 2022, Turkish Society of Cardiovascular Surgery.)